Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
public-private partnership
|
| gptkbp:CEO |
Catherine Ohura
|
| gptkbp:collaboratesWith |
nonprofit organizations
international research organizations Japanese pharmaceutical companies |
| gptkbp:focus |
global health
infectious diseases tuberculosis malaria neglected tropical diseases neglected diseases |
| gptkbp:founded |
2013
|
| gptkbp:fullName |
gptkb:Global_Health_Innovative_Technology_Fund
|
| gptkbp:fundedBy |
gptkb:Government_of_Japan
gptkb:Bill_&_Melinda_Gates_Foundation gptkb:Wellcome_Trust pharmaceutical companies |
| gptkbp:headquartersLocation |
gptkb:Tokyo,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
GHIT Fund
|
| gptkbp:mission |
accelerate development of new health technologies for the developing world
|
| gptkbp:regionServed |
global
|
| gptkbp:typeOfProjects |
vaccine development
drug development diagnostic development |
| gptkbp:website |
https://www.ghitfund.org/
|
| gptkbp:bfsParent |
gptkb:Global_Health_Innovative_Technology_Fund
|
| gptkbp:bfsLayer |
7
|